Skip to main content
Caplight Logo









CrestecBio Inc.

CrestecBio Inc.

Private
IbarakiHealthcare & Life Scienceshttps://crestecbio.com/

Last Round

Seed

Dec 9, 2025

Total Funding Raised

$1.6M

Company Overview

CrestecBio Inc. is a biotechnology company that develops polymer-based nanomedicines, specifically redox nanoparticles, for the treatment of oxidative stress-related diseases such as ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

nanomedicinepolymeric micellesredox nanoparticlesneuroprotectionischemic stroke treatmentdrug discoverybiotech startuppharmaceutical licensingoxidative stresscerebral ischemiadrug developmentbiopharmaclinical trialstherapeutic pipelinedrug delivery systems

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CrestecBio Inc. Comparables

Compare CrestecBio Inc. with similar companies based on industry and business-model similarity.

CrestecBio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Basking Biosciences
68%
NoNO Inc.
65%
Tanabe Pharma Corporation
61%

CrestecBio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 9, 2025
AngelFeb 21, 2023

Key People

Founding team and executive leadership

Aiki Marushima

CEO

Executive Team

CrestecBio Inc. Investors

Notable investors and investment history

CrestecBio Inc. investors
InvestorRounds
Newsight Tech AngelsAngel
Japan Science and Technology AgencySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 32% MoM, reaching 1.2K.

  • Jan 7, 2026

    Monthly visitors increased 62% MoM, reaching 1.5K.

CrestecBio Inc. Filings

Explore SEC and related filing metadata, where available.

CrestecBio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CrestecBio Inc.'s valuation, stock price, and market status.

Is CrestecBio Inc. a public or private company?

CrestecBio Inc. is a private company.

What is the current stock price of CrestecBio Inc.?

CrestecBio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is CrestecBio Inc. worth (valuation)?

Valuation information for CrestecBio Inc. is not publicly available.

Can I buy CrestecBio Inc. stock?

CrestecBio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CrestecBio Inc.'s last funding round?

CrestecBio Inc.'s most recent funding round was Seed on December 9, 2025.

Who are the main investors in CrestecBio Inc.?

Key investors in CrestecBio Inc. include Newsight Tech Angels, Japan Science and Technology Agency.

Will CrestecBio Inc. IPO soon?

No public IPO plans have been announced for CrestecBio Inc..

How can I track CrestecBio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CrestecBio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIbaraki
Employee Range3
Year Founded2021
Last FundingDec 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?